USFDA Inspection | The Health Master

Home Tags USFDA Inspection

USFDA Inspection

Industry

Indian Pharma Industry wants to end multiple inspections by USFDA

The Health Master -

July 22, 2023

USFDA Inspection

Industry

Committee asks USFDA to submit details on inspection of Pharma Companies in India and China

The Health Master -

July 21, 2023

Industry

USFDA issues Form 483 with one observation to Gland Pharma: Hyderabad

The Health Master -

July 15, 2023

Industry

USFDA issues Form 483 to Lupin with 2 observations: Nagpur

The Health Master -

July 13, 2023

USFDA Inspection

Industry

USFDA completes inspection of Granules India in two facilities

The Health Master -

July 2, 2023

Industry

USFDA issues Form 483 with one observation to Gland Pharma: Hyderabad

The Health Master -

June 27, 2023

USFDA Inspection

Industry

USFDA completes inspection at Ajanta Pharma with zero observations: Gujarat

The Health Master -

June 26, 2023

USFDA Inspection

Industry

Lupin gets EIR from US FDA for its API manufacturing facility in Vizag

The Health Master -

June 20, 2023

Industry

USFDA concludes inspection at Zydus with zero observations

The Health Master -

June 19, 2023

USFDA Inspection

Industry

USFDA completes inspection of Dr Reddy’s with zero observations

The Health Master -

June 18, 2023

Industry

USFDA issues Form 483 with 11 observations IPCA Labs: Ratlam

The Health Master -

June 17, 2023

USFDA Inspection

Industry

USFDA completes inspection of JB Pharma with zero observations: Gujarat

The Health Master -

June 14, 2023

USFDA Inspection

Industry

USFDA completes inspection of Biocon with zero observations: Bengaluru

The Health Master -

June 5, 2023

USFDA Inspection

Industry

USFDA completes inspection of Zydus Lifesciences with zero observations

The Health Master -

June 4, 2023

USFDA Inspection

Industry

USFDA inspection at Alembic completed without any observations: Gujarat

The Health Master -

March 13, 2023

Industry

USFDA issues Form 483 with zero observations to Solara Active Pharma Sciences Vizag Facility

The Health Master -

January 30, 2023

USFDA Inspection

Industry

USFDA issues zero observations for Gland Pharma API Facility

The Health Master -

January 28, 2023

USFDA Inspection

Industry

USFDA gives 13 observations to Lupin

The Health Master -

April 4, 2022

USFDA Inspection

Industry

USFDA inspection ends with ‘Zero’ observations: Alkem

The Health Master -

July 31, 2021

1...3 45Page 5 of 5

Archives

Authors

138 POSTS0 COMMENTS

40 POSTS0 COMMENTS

40 POSTS0 COMMENTS

20 POSTS0 COMMENTS

13 POSTS0 COMMENTS

Dr. Kumud Madan

13 POSTS0 COMMENTS

11 POSTS0 COMMENTS

Sushant Mahapatra

9 POSTS0 COMMENTS

Dr. Bharatesh R Jagashetty

7 POSTS0 COMMENTS

5 POSTS0 COMMENTS

5 POSTS0 COMMENTS

Manmohan Taneja

5 POSTS0 COMMENTS

Dr. Brahmdeep Sindhu

4 POSTS0 COMMENTS

4 POSTS0 COMMENTS

3 POSTS0 COMMENTS

http://www.pharmastute.com

3 POSTS0 COMMENTS

2 POSTS0 COMMENTS

Dr. P K Sreekumar

2 POSTS0 COMMENTS

1 POSTS0 COMMENTS

1 POSTS0 COMMENTS

Sanjay Malhotra

1 POSTS0 COMMENTS

http://www.aerolgroup.com

1 POSTS0 COMMENTS

Dr. Balraj Yadav

1 POSTS0 COMMENTS

Dr. Gulshan Rai Arora

1 POSTS0 COMMENTS

Prof Vivek Padgaonkar

1 POSTS0 COMMENTS

https://www.linkedin.com/in/vivek-padgaonkar-8298509/

1 POSTS0 COMMENTS